Biogen Market Cap

Biogen has a market cap or net worth of $31 billion as of August 14, 2026. Its market cap has increased by 56.42% in one year.

Market Cap

31.00B

Enterprise Value

38.07B

1-Year Change

56.42%

Ranking

#468

ChartMarket Cap Chart

Chart

Since December 1, 1998, Biogen's market cap has increased from $617.50M to $31.00B, an increase of 4,920.76%. That is a compound annual growth rate of 15.17%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2026	31.00B	20.08%
Dec 31, 2025	25.82B	15.86%
Dec 31, 2024	22.28B	-40.57%
Dec 29, 2023	37.50B	-5.97%
Dec 30, 2022	39.88B	13.15%
Dec 31, 2021	35.24B	-6.47%
Dec 31, 2020	37.68B	-29.63%
Dec 31, 2019	53.54B	-11.69%
Dec 31, 2018	60.63B	-10.00%
Dec 29, 2017	67.37B	9.19%
Dec 30, 2016	61.70B	-9.65%
Dec 31, 2015	68.29B	-14.82%
Dec 31, 2014	80.16B	21.39%
Dec 31, 2013	66.04B	90.69%
Dec 31, 2012	34.63B	29.54%
Dec 30, 2011	26.73B	67.31%
Dec 31, 2010	15.98B	3.27%
Dec 31, 2009	15.47B	11.34%
Dec 31, 2008	13.90B	-16.78%
Dec 31, 2007	16.70B	0.70%
Dec 29, 2006	16.58B	7.90%
Dec 30, 2005	15.37B	-30.83%
Dec 31, 2004	22.22B	288.89%
Dec 31, 2003	5.71B	12.55%
Dec 31, 2002	5.08B	-51.71%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Novartis AG	290.81B
AstraZeneca	245.13B
Amgen	226.11B
Novo Nordisk	204.47B
Gilead Sciences	169.87B
Pfizer	153.38B
Bristol-Myers Squibb Company	132.69B
Sanofi	104.29B

Market Cap Rankings